Showing results (81-90 of 157) with videos related to
Sort By:
Pageof 16
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptorsChia-Chi Lin, Hsin-Hsin Hsu, Chia-Tung Sun, et al.Contemporary Oncology (Poznan, Poland)|February 26, 2024
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening TrialRafal Dziadziuszko, Nir Peled, Tony Mok, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2016
Systematic evaluation of circulating inflammatory markers for hepatocellular carcinomaStephen L Chan, Anthony W H Chan, Allen K C Chan, et al.JAMA Oncology|January 1, 2016
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION StudyKeunchil Park, Chong-Jen Yu, Sang-We Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trialJean-Yves Douillard, Frances A Shepherd, Vera Hirsh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN StudyBenjamin J Solomon, Todd M Bauer, Sai-Hong Ignatius Ou, et al.International Journal of Cancer|November 24, 2020
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China StudyYi-Long Wu, Li Zhang, Yun Fan, et al.Nature Communications|December 8, 2025
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral bloodYang Xia, Yin Zhu, Sai Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2Lucio Crinò, Myung-Ju Ahn, Filippo De Marinis, et al.The Journal of Clinical Investigation|June 10, 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistanceKang-Seo Park, Mark Raffeld, Yong Wha Moon, et al.Pageof 16